BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32455867)

  • 1. Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.
    Sasahira T; Kurihara-Shimomura M; Nishiguchi Y; Shimomura H; Kirita T
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LEM domain containing 1 promotes oral squamous cell carcinoma invasion and endothelial transmigration.
    Sasahira T; Kurihara M; Nakashima C; Kirita T; Kuniyasu H
    Br J Cancer; 2016 Jun; 115(1):52-8. PubMed ID: 27280633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis.
    Sasahira T; Kurihara-Shimomura M; Shimomura H; Kirita T
    Int J Clin Oncol; 2021 Oct; 26(10):1831-1839. PubMed ID: 34173120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trks are novel oncogenes involved in the induction of neovascularization, tumor progression, and nodal metastasis in oral squamous cell carcinoma.
    Sasahira T; Ueda N; Yamamoto K; Bhawal UK; Kurihara M; Kirita T; Kuniyasu H
    Clin Exp Metastasis; 2013 Feb; 30(2):165-76. PubMed ID: 22886570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.
    Ghosh S; Koblinski J; Johnson J; Liu Y; Ericsson A; Davis JW; Shi Z; Ravosa MJ; Crawford S; Frazier S; Stack MS
    Mol Cancer Res; 2010 Feb; 8(2):145-58. PubMed ID: 20145038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
    Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
    J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
    Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
    BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sushi repeat-containing protein X-linked 2 promotes angiogenesis through the urokinase-type plasminogen activator receptor dependent integrin αvβ3/focal adhesion kinase pathways.
    Liu K; Fan J; Wu J
    Drug Discov Ther; 2017; 11(4):212-217. PubMed ID: 28867754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma.
    Uzawa K; Amelio AL; Kasamatsu A; Saito T; Kita A; Fukamachi M; Sawai Y; Toeda Y; Eizuka K; Hayashi F; Kato-Kase I; Sunohara M; Iyoda M; Koike K; Nakashima D; Ogawara K; Endo-Sakamoto Y; Shiiba M; Takiguchi Y; Yamauchi M; Tanzawa H
    Sci Rep; 2019 Aug; 9(1):12179. PubMed ID: 31434965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell chymase promotes angiogenesis and lymphangiogenesis mediated by activation of melanoma inhibitory activity gene family members in oral squamous cell carcinoma.
    Kurihara-Shimomura M; Sasahira T; Shimomura H; Bosserhoff AK; Kirita T
    Int J Oncol; 2020 May; 56(5):1093-1100. PubMed ID: 32319583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX3 plays a tumor suppressor role by inhibiting cell migration, invasion and angiogenesis in oral squamous cell carcinoma.
    Zhou WN; Du YF; Bai J; Song XM; Zheng Y; Yuan H; Zhang W; Zhang ZD; Wu YN
    Oncol Rep; 2017 Oct; 38(4):2378-2386. PubMed ID: 28765934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA LEMD1-AS1 Increases LEMD1 Expression and Activates PI3K-AKT Pathway to Promote Metastasis in Oral Squamous Cell Carcinoma.
    Li Z; Wang J; Wu J; Li N; Jiang C
    Biomed Res Int; 2022; 2022():3543948. PubMed ID: 35983249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
    Wu HM; Cao W; Ye D; Ren GX; Wu YN; Guo W
    Mol Med Rep; 2012 Aug; 6(2):265-70. PubMed ID: 22580838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary-type plasminogen activator receptor (uPAR) modulates oral cancer cell behavior with alteration in p130cas.
    Shi Z; Liu Y; Johnson JJ; Stack MS
    Mol Cell Biochem; 2011 Nov; 357(1-2):151-61. PubMed ID: 21630091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS.
    Yuan Y; Xie X; Jiang Y; Wei Z; Wang P; Chen F; Li X; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Wang Z; Chen Q
    Cell Death Dis; 2017 Sep; 8(9):e3035. PubMed ID: 28880263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
    Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
    J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.